OMCL

Omnicell, Inc. (OMCL) ESG Analysis Analysis (2026)

Invetso Score: 6.9/10 — Balanced · Last Updated: 2026-08-01

Environmental

OMCL’s R&D intensity is moderate versus medtech peers, supporting product innovation but implying a typical resource footprint rather than a clear sustainability advantage.

The company’s low leverage reduces balance-sheet pressure that can constrain environmental capex, yet it does not by itself indicate superior environmental management versus peers.

No disclosed emissions, energy, or waste metrics were provided, limiting evidence of environmental leadership and keeping the score anchored near peer-average positioning.

Absent Tier 1 sustainability disclosures, OMCL cannot be distinguished from peers on environmental risk management, so the profile remains moderate rather than strong.

Social

OMCL’s R&D-to-revenue ratio suggests continued investment in product quality and clinical utility, which can support patient and customer outcomes versus lower-investing peers.

Stock-based compensation is modest relative to revenue, indicating limited dilution pressure and a compensation structure that is not unusually aggressive versus peers.

No workforce, safety, diversity, or product-responsibility disclosures were provided, so social positioning cannot be confirmed as stronger than peers.

Without evidence on recalls, training, or employee metrics, OMCL’s social profile remains broadly in line with peers rather than clearly differentiated.

Governance

OMCL’s low debt-to-equity ratio indicates conservative capital structure discipline, reducing creditor pressure and supporting governance flexibility versus more leveraged peers.

Negative net debt to EBITDA suggests net cash positioning, which typically lowers refinancing risk and strengthens board room for oversight and capital allocation.

Stock-based compensation at 2.6% of revenue appears restrained, implying less shareholder dilution and better alignment than many medtech peers.

No filing-based evidence of governance controversies or control failures was provided, so the main relative advantage is disciplined balance-sheet governance.

Overall Score

OMCL’s ESG profile is moderate overall, with governance strongest on conservative leverage and compensation discipline, while environmental and social evidence remains limited versus peers.

Score Driver: Conservative Leverage And Modest Stock-Based Compensation Are The Clearest Relative ESG Strengths.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Omnicell, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →